Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $14.20M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −59.2% to +49.0% across the middle 80 percent of the group, with a median of −31.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| GSS.AX | Genetic Signatures Limited | $14.20M | Micro cap | −71.00% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.14M | Micro cap | −41.54% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.